BC-CfE researchers will be presenting at this year’s AIDS 2016 conference

IAS 2016

The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.

The AIDS 2016 programme will present new scientific knowledge and offer many opportunities for structured dialogue on the major issues facing the global response to HIV. A variety of session types – from abstract-driven presentations to symposia, bridging and plenary sessions – will meet the needs of various participants. Other related activities, including the Global Village, satellite symposia, the Exhibition and affiliated independent events, will contribute to an exceptional opportunity for professional development and networking.

The AIDS 2016 conference will be held at the Durban International Convention Centre (ICC) from 18 to 22 July 2016.

Click HERE to visit the AIDS 2016 website for more information

Once again, BC-CfE researchers will be presenting at this year’s AIDS 2016 conference.


Presenters Presentation Date Topic PDF Downloads
Alyssa Ferguson Tuesday, July 19th Interpersonal and structural factors of non-condom use with intimate partners among sex workers in conflict-affected northern Uganda
Will Small Tuesday, July 19th Re-initiation of antiretroviral therapy (ART) following treatment interruption among HIV-positive people who inject drugs (PWID)
Allison Carter Tuesday, July 19th Love with HIV: a latent class analysis of intimate relationships among women living with HIV enrolled in Canada´s largest multisite community-based research study
Genevieve Kerkerian Tuesday, July 19th Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada
Lindsey Richardson Tuesday, July 19th Long-term labour market attachment predicts key antiretroviral therapy outcomes among people who use illicit drugs in a setting of universal HIV health care coverage
Ofer Amram Wednesday, July 20th The impact of distance to HIV care on adherence to treatment: adjusting for population and geographical heterogeneity using advanced spatial analysis
Karina Czyzewski Wednesday, July 20th Integrated and assertive HIV treatment and care within housing among women living with HIV: balancing support with privacy and self-determination
Ryan McNeil Wednesday, July 20th Antiretroviral therapy interruption among people who use drugs in a setting with a community-wide HIV treatment as prevention initiative
Karina Czyzewski Wednesday, July 20th Indigenous women-centered HIV care: responding to culture and safety
Pauline Voon Thursday, July 21st Engagement in HIV/AIDS care and likelihood of viral suppression are unaffected by high-intensity cannabis use among people who use illicit drugs living with HIV/AIDS
Maria Eugenia Socias Thursday, July 21st Methadone maintenance therapy and viral suppression among HIV-infected opioid users: the impacts of crack and injection cocaine use
Brittany Barker Thursday, July 21st HIV risk associated with suicide attempts among a prospective cohort of street-involved youth
Pauline Voon Thursday, July 21st High functional pain interference is associated with active injection drug use among a cohort of HIV-positive people who use illicit drugs in Vancouver, Canada
Kalysha Closson Thursday, July 21st Gendered prevalence and predictors of potentially traumatic experiences of young men and women in Soweto, South Africa
Mary Clare Kennedy Thursday, July 21st Social and structural factors associated with greater time above an HIV viral load of 1500 copies/mL plasma among illicit drug users in a Canadian setting
Allison Carter Thursday, July 21st Factors shaping a high prevalence of ever and recent incarceration experience among women living with HIV in Canada
Andrea Krüsi Thursday, July 21st Positive sexuality: HIV, gender, power, intimacy and the law
Allison Carter Thursday, July 21st Impacts and responses for substance use among Canadian women living with HIV: a latent class analysis
Sally Lin Thursday, July 21st Challenges and opportunities for improving early initiation of ART: a thematic analysis of experiences among individuals recently diagnosed with HIV
Mint Ti Thursday, July 21st The impact of patient-provider attachment on HIV-1 RNA plasma viral load suppression among people living with HIV/AIDS in British Columbia
Share the Post:
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)